DHR · Danaher Corporation

Summary

Danaher Corporation announced entry into a definitive Merger Agreement dated February 16, 2026, to acquire all outstanding shares of Masimo Corporation for $180 per share in cash, representing an enterprise value of approximately $9.9 billion. The transaction is subject to customary conditions including regulatory approvals and Masimo shareholder approval, with closing anticipated in the second half of 2026.

Key takeaways

• Danaher to acquire Masimo Corporation via merger with Merger Sub
• Consideration: $180.00 per share in cash
• Enterprise value: approximately $9.9 billion including assumed indebtedness and net of acquired cash
• Merger Agreement dated February 16, 2026
• Closing expected second half of 2026
• Conditions: HSR waiting period, non-U.S. antitrust approvals, Masimo shareholder approval
• Masimo to operate standalone in Danaher’s Diagnostics segment